Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
SpaceX rocket launches 140 satellites into orbit on Transporter-15, aces landing at sea (video) - 2Uncover the Manageable Fish Practices: Sea agreeable Feasting
- 3Blue Origin launches huge rocket carrying twin NASA spacecraft to Mars
- 4Without evidence, CDC changes messaging on vaccines and autism
- 5How Skoda Lost Its Biggest Market In Just Seven Years
- Grasping Various Kinds of Local misdemeanors
- A24's 'Backrooms' trailer shows endless fluorescent-lit spaces and terrifying mannequins melting into the floor
- November Lease Deals for the 2025 Kia EV6 are Too Good to Pass Up
- January’s full wolf supermoon and the Quadrantid meteor shower will start off the new year
- AstraZeneca to acquire Modella AI to speed oncology drug research
- Must-See Public Parks from Around the Globe
- Idris Elba is the king of the stress-watch
- Examination In progress into Abuse of Japanese Government-Supported Advance
- Vacation destinations in America
